trending Market Intelligence /marketintelligence/en/news-insights/trending/wkpyxu28utbqqnr7f8abfw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Walgreens to pay $5.5M in drug overcharge probe

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Walgreens to pay $5.5M in drug overcharge probe

Walgreens Boots Alliance Inc.'s Walgreen Co. agreed to pay $5.5 million after allegedly overcharging workers for prescription drugs covered by the state workers' compensation insurance, according to a March 20 release from the Office of Attorney General Maura Healey.

Between 2008 and 2017, the Illinois-based drug retailer allegedly violated state consumer protection law by overcharging its workers for legitimate prescription drugs at various Walgreen pharmacies in Massachusetts. The drugs were covered by the employees' compensation insurance system, which takes care of certain medical expenses incurred by workers injured on the job.

"This settlement ensures that Walgreens does not profit from those transactions," Healey said.

As part of the settlement, the drug retailer will have to implement procedures to check overcharges on opioids and other drugs under the workers' compensation system in the future. In addition, future sales of the pharmacy chain will be subjected to an audit review by the attorney general's office.